Advanced company searchLink opens in new window

AXALBION THERAPEUTICS LIMITED

Company number 13224059

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Nov 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
25 Oct 2023 MR01 Registration of charge 132240590002, created on 20 October 2023
20 Jun 2023 CS01 Confirmation statement made on 6 June 2023 with no updates
20 Mar 2023 AA Total exemption full accounts made up to 31 December 2022
06 Mar 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
01 Mar 2023 MR01 Registration of charge 132240590001, created on 27 February 2023
05 Jul 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
28 Jun 2022 AA Total exemption full accounts made up to 31 December 2021
06 Jun 2022 CS01 Confirmation statement made on 6 June 2022 with updates
18 Feb 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
16 Feb 2022 SH01 Statement of capital following an allotment of shares on 7 February 2022
  • GBP 1,247,713.3
17 Dec 2021 SH01 Statement of capital following an allotment of shares on 17 December 2021
  • GBP 1,083,749.8
09 Dec 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Company business 24/11/2021
  • RES10 ‐ Resolution of allotment of securities
03 Nov 2021 CS01 Confirmation statement made on 3 November 2021 with updates
03 Jun 2021 AA01 Current accounting period shortened from 28 February 2022 to 31 December 2021
22 Apr 2021 PSC07 Cessation of Ashley Arthur Woodcock as a person with significant control on 16 March 2021
14 Apr 2021 AP01 Appointment of Michael Kitt as a director on 31 March 2021
12 Apr 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
03 Apr 2021 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Apr 2021 MA Memorandum and Articles of Association
26 Mar 2021 AP01 Appointment of Paul Hartley Glyer as a director on 16 March 2021
25 Mar 2021 AP01 Appointment of Mr Adrian Ivery Field as a director on 16 March 2021
25 Mar 2021 AP01 Appointment of Marc-Henry Peppo Jules Rochat as a director on 16 March 2021
25 Mar 2021 SH01 Statement of capital following an allotment of shares on 16 March 2021
  • GBP 716,715
25 Mar 2021 PSC01 Notification of Jonathan Paul Moulton as a person with significant control on 16 March 2021